Maui Derm NP+PA Fall 2024 Program

September 15-18, 2024 • Gaylord Opryland  •  Nashville, TN

Print Agenda
TimeSunday, September 15, 2024Faculty
7:00 am – 7:50 am Breakfast, Exhibits & Registration
(GOVERNOR’S BALLROOM)
7:50 am – 8:00 am Welcome & Program Overview
(GOVERNOR’S BALLROOM)
8:00 am – 9:30 am Literature from 2023 & 2024 in Review
(GOVERNOR’S BALLROOM)
Drs. Ted Rosen, Sheila Fallon Friedlander and Matt Zirwas will discuss the most noteworthy articles from a wide array of journals published in the last year. 		T. Rosen, MD
S. Fallon-Friedlander, MD
M. Zirwas, MD
9:30 am – 10:30 amNew Products and New Therapies
(GOVERNOR’S BALLROOM)
Drs. Ted Rosen and George Martin will discuss the newest drugs and therapies and how you will be using them in 2024 and beyond.    		T. Rosen, MD
G. Martin, MD
10:30 am -11:15 amBreaks + Exhibits
(GOVERNOR’S BALLROOM)
11:15 am – 12:45 pmUpdate Cutaneous Oncology 2024 – New Interactive Format
(GOVERNOR’S BALLROOM)
Drs. Rosen and Martin will cover their approach from AKs to advanced BCC and SCC. In the second part of the session, a series of challenging case scenarios will be presented. Attendees will then be asked during case studies to weigh in on their selection of therapies on a survey app. Drs. Rosen and Martin will then discuss the rationale for their therapeutic selection. 		T. Rosen, MD
G. Martin, MD
12:45 pm – 1:15 pmQ&A
(GOVERNOR’S BALLROOM)
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater. 		T. Rosen, MD
G. Martin, MD
M. Zirwas, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm		Product Theater Luncheon hosted by AbbVie (Non-CME)
(GOVERNOR’S BALLROOM)
“Raising the Bar”
Speaker: Kirk Gautier, PA
INDUSTRY HOSTED EVENT
1:45 pm – 2:15 pm		Dessert Product Theater hosted by Amgen (Non-CME)
(GOVERNOR’S CHAMBER D/E)
Modern Dialogue for Patient Care
Speaker: Douglas DiRuggiero, PA-C
2:15 pm – 4:00 pmPsoriasis and Psoriatic Arthritis Update 2024 – New Interactive Format
(GOVERNOR’S BALLROOM)
Our expert faculty will discuss what is new in PsO and PsA in the last year, including new drugs and therapies. In the second part of the session, a series of challenging case scenarios in PsO and PsA will be presented. Attendees will then be asked during case studies to weigh in on their selection of therapies on a survey app. Our faculty will then discuss the rationale for their therapeutic selection. 		Moderator:
G. Martin, MD

Panel:
J. Hawkes, MD
K. Shaw, MD
M. Young, MSN, ANP-c
INDUSTRY HOSTED EVENT
4:00 pm – 4:30 pm		Product Theater Reception hosted by UCB, Inc. (Non-CME)
(GOVERNOR’S CHAMBER D/E)
Bimzelx has Arrived!
Speaker: Raj Chovatiya, MD, PHD, MSCI, FAAD
6:00 pm – 7:00 pmWelcome Reception
(TENNESSEE BALLROOM A/B
TimeMonday, September 16, 2024Faculty
INDUSTRY HOSTED EVENT
7:00 am – 7:30 am		Breakfast Product Theater hosted by Arcutis (Non-CME)
(GOVERNOR’S BALLROOM)
Treatment Innovation: Discover ZORYVE (roflumilast) 0.15% for a new indication
Speaker: Raj Chovatiya, MD, PhD, MSCI
7:00 am – 7:55 amBreakfast + Exhibits
(GOVERNOR’S BALLROOM)
7:55 am – 8:00 amMorning Announcements
(GOVERNOR’S BALLROOM)
8:00 am – 9:00 am Infectious Disease Update
(GOVERNOR’S BALLROOM)
Drs. Rosen and Hightower will discuss diagnostic and therapeutic challenges in children and adults covering a range of viral, bacterial, fungal, parasitic and arthropod diseases.  		T. Rosen, MD
G. Hightower, MD
9:00 am – 9:45 amConnective Tissue Disorders Update 2024
(GOVERNOR’S BALLROOM)
Lupus, Scleroderma, Dermatomyositis and more. What are the latest in diagnostic and therapeutic developments in connective tissue disorders. Learn from one of the world experts in connective tissue disorders. 		K. Shaw, MD
9:45 am – 10:30 amDisorders of Pigmentation
(GOVERNOR’S BALLROOM)
Disorders of pigmentation are part of everyday dermatology practice. In this session our faculty will discuss their approach to disease states such as melasma, vitiligo and more. During the case based discussion, they will share their diagnostic approach, including differential diagnoses to consider, and the latest strategies used to manage a wide range of pigmentation disorders. 		V. Callender, MD
10:30am -11:15amBreaks + Exhibits
(GOVERNOR’S BALLROOM)
11:15 am – 12:15 pmGrand Rounds in Dermatology – New Interactive Format
(GOVERNOR’S BALLROOM)
Our expert faculty will present cases that challenged their clinical skills in making the diagnosis and deciding on a therapeutic regimen. After being presented with the clinical scenario, attendees will be asked to weigh in on their selection of therapies on the meeting app. Our faculty will then discuss the rationale for their therapeutic selection. Pay attention as each case that will be presented required an extensive differential diagnosis and, in some cases, a diagnostic workup and full armamentarium of therapeutic agents. 		Moderator:
G. Martin, MD

Faculty:
T. Rosen, MD
A. Kirkorian, MD
12:15 pm – 12:45 pmThe Challenge of the Lower Leg Ulcer
(GOVERNOR’S BALLROOM)
Lower leg ulcers present to our clinic on a regular basis. Figuring out what caused them can be a complicated issue. Your immediate and long-term diagnostic and therapeutic strategies need a working diagnosis. Traumatic, vascular, systemic disease associated, infectious are among the causes of leg ulcers that require you to establish a diagnostic and therapeutic plan. Dr. Grada, dermatologist and leading expert in this arena, will walk you through a number of clinically challenging cases and his diagnostic and therapeutic approach to them. 		A. Grada, MD
12:45 pm – 1:15 pmQ&A
(GOVERNOR’S BALLROOM)
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater. 		A. Grada, MD
T. Rosen, MD
G. Martin, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm		Product Theater Luncheon hosted by Pfizer (Non-CME)
(GOVERNOR’S BALLROOM)
Advance your Knowledge: An Oral Treatment for Severe Alopecia Areata
Speaker: Dr. Matthew Zirwas
INDUSTRY HOSTED EVENT
1:45 pm – 2:15 pm		Dessert Product Theater hosted by Eli Lilly and Company (Non-CME)
(GOVERNOR’S CHAMBER D/E)
Olumiant in Action: 3-Year Data
Speaker: Leigh Ann Pansch, MSN, FNP-BC
2:15 pm – 3:00 pmHidradenitis Suppuritiva Update 2024
(GOVERNOR’S BALLROOM)
HS is one of the most challenging clinical situations managed by the dermatologist. A combination of medical and surgical management strategies is needed to optimize therapies. The introduction of new therapies and how they will be used will be discussed.		R. Chovatiya MD, PhD
3:00 pm – 4:00 pmAcute & Chronic Spontaneous Urticaria: Diagnostic and Therapeutic Strategies
(GOVERNOR’S BALLROOM)
Dr. Hawkes will present a series of challenging cases in urticaria that will test your knowledge in making the correct diagnosis and appropriate therapy. Attendees , after being presented with a wide range of clinical scenarios will be asked to weigh in on their selection of therapies on a survey app. Dr. Hawkes will then discuss the rationale for his therapeutic selection. 		J. Hawkes, MD
INDUSTRY HOSTED EVENT
6:00 pm – 7:30 pm
Medical Symposium hosted by Leo Pharma (Non-CME)
(GOVERNOR’S CHAMBER D/E)
Chronic Hand Eczema – A New Day is at Hand
Speaker: Raj Chovatiya, MD, PhD, MSCI
Dinner will be served at 6:15
TimeTuesday, September 17, 2024Faculty
INDUSTRY HOSTED EVENT
7:00 am – 7:30 am 		Breakfast Product Theater hosted by Almirall (Non-CME)
(GOVERNOR’S BALLROOM)
Discover the Modern Face of Actinic Keratosis (AK) Field Therapy
Speaker: James Del Rosso, DO
7:00 am – 7:55 am Breakfast + Exhibits
(GOVERNOR’S BALLROOM)
7:55 am – 8:00 am Morning Announcements
(GOVERNOR’S BALLROOM)
8:00 am – 9:00 am Pediatric Dermatology Update 2024
(GOVERNOR’S BALLROOM)
Three of the foremost pediatric dermatologists will bring the latest in diagnostic and therapeutic approaches to a wide range of diagnostic and therapeutic scenarios involving neonates and children. 		V. Oza, MD
G. Hightower, MD, PhD
A. Kirkorian, MD
9:00 am – 10:30 amAtopic Dermatitis and Itch Update 2024 – New Interactive Format
(GOVERNOR’S BALLROOM)
New drugs, new data, new approaches to treating atopic dermatitis and itch will be discussed in the first part of the session. In the last part of the session, a series of challenging case scenarios will be presented. After being presented with the clinical scenario, attendees will be asked to weigh in on their selection of therapies on a survey app. Our faculty will then discuss the rationale for their therapeutic selection. 		M. Zirwas, MD
V. Oza, MD
G. Martin, MD
10:30 am -11:15 amBreaks + Exhibits
(GOVERNOR’S BALLROOM)
11:00 am – 12:45 pmAcne and Rosacea Update 2024 – New Interactive Format
(GOVERNOR’S BALLROOM)
Drs. Hilary Baldwin, Julie Harper and James Del Rosso will discuss the latest in their approach to treating acne and rosacea. In the second part of the session, a series of challenging case scenarios will be presented. After being presented with case scenarios, attendees will then be asked to weigh in on their selection of therapies on a survey app. Our faculty will then discuss the rationale for their therapeutic selection. 		H. Baldwin, MD
J. Harper, MD
J. Del Rosso, DO
12:45 pm – 1:15 pmQ&A
(GOVERNOR’S BALLROOM)
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater. 		G. Martin, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm		Product Theater Luncheon hosted by Incyte (Non-CME)
(GOVERNOR’S BALLROOM)
Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway for JAK Inhibition
Speaker: James Del Rosso, DO
INDUSTRY HOSTED EVENT
1:45 pm – 2:15 pm		Dessert Product Theater hosted by Sanofi and Regeneron Pharmaceuticals (Non-CME)
(GOVERNOR’S BALLROOM)
A Treatment Option for Appropriate Patients With Atopic Dermatitis or Prurigo Nodularis. Description: Learn more about a treatment option that may help appropriate patients with atopic dermatitis or prurigo nodularis.
Speaker: Lindsay Greer Frazier, BSN, MSN, FNP-BC
2:15 pm – 3:15 pmLightening Round: Skin Lesions Associated with Systemic Disease
(GOVERNOR’S BALLROOM)
During this interactive session our faculty will present a series of challenging clinical photos and you will be asked to select the correct answer. The skin lesions are clues to underlying systemic disease. Test your clinical acumen against your peers! 		Moderator:
G. Martin, MD

Faculty:
T. Rosen, MD
S. Fallon Friedlander, MD
3:15 pm – 4:15 pmHair Update 2024
(GOVERNOR’S BALLROOM)
As the song goes, “nobody does it better”. Dr. Jerry Shapiro continues to deliver the most comprehensive and cutting edge talk on non-scarring and scarring alopecias. 		J. Shapiro, MD
TimeWednesday, September 18, 2024Faculty
7:00 am – 7:55 am Breakfast + Exhibits
(GOVERNOR’S BALLROOM)
7:55 am – 8:00 am Morning Announcements
(GOVERNOR’S BALLROOM)
8:00 am – 8:45 am Contact Dermatitis: Cases that will leave you scratching your head – New Interactive Format
(GOVERNOR’S BALLROOM)
Dr. Zirwas will present a series of cases that will have you “scratching your head” in coming up with a diagnosis. Learn as our contact dermatitis “super sleuths” lead you on a diagnostic and therapeutic journey during a wide range of “eczematous conditions”. Attendees, after being presented with case scenarios, will then be asked to weigh in on their diagnosis and therapeutic choices on a survey. Our faculty will then discuss the rationale for their diagnostic and therapeutic selection. 		M. Zirwas, MD
8:45 am – 10:00 amBlistering Diseases: What’s the Diagnosis – New Interactive Format
(GOVERNOR’S BALLROOM)
Dr. Donna Culton will present a series of blistering disease cases that will challenge your diagnostic and therapeutic acumen. Attendees, after being presented with case scenarios, will then be asked to weigh in on their diagnosis and therapeutic choices on the survey app. Dr. Culton will then discuss the diagnosis and the rationale for her therapeutic selection. 		D. Culton, MD, PhD
10:00 am -10:45 amBreaks + Exhibits
(GOVERNOR’S BALLROOM)
10:45 am – 12:45 pmPigmented Lesion Clinic – New Interactive Format
(GOVERNOR’S BALLROOM)
Take three world experts in the diagnosis and management of pigmented lesions and have them discuss their approach to a wide array of clinical scenarios involving the spectrum of pigmented lesions from congenital nevi to metastatic melanoma. They will present a series of pigmented lesion cases that will challenge your diagnostic and therapeutic acumen. After being presented with case scenarios, attendees will be asked to weigh in on their diagnosis and therapeutic choices on the survey app. The faculty will then discuss the diagnosis and the rationale for her therapeutic selection. 		H. Tsao, MD, PhD
E. Hawryluk, MD, PhD
A. Marghoob, MD
12:45 pm – 1:15 pmQ&A
(GOVERNOR’S BALLROOM)
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater. 		H. Tsao, MD, PhD
A. Marghoob, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm		Product Theater Luncheon hosted by Novartis (Non-CME)
(GOVERNOR’S BALLROOM)
Exploring Patient Burden and BTK-Driven Immune Dysregulation in CSU
Speaker: Ellen Menefee, DMSc, MPAS
INDUSTRY HOSTED EVENT
1:45 pm – 2:15 pm		Dessert Product Theater hosted by Sun Pharma (Non-CME)
(GOVERNOR’S CHAMBER D/E)
Clinical Updates for WINLEVI (clascoterone) Cream 1%
Speaker: Hilary E. Baldwin, MD
2:15 pm – 4:45 pmWorkshop: Dermoscopy on Special Sites
(GOVERNOR’S BALLROOM)
Simply described as “the best dermoscopy workshop you will ever attend”. Dr. Ash Marghoob will hold his internationally acclaimed workshop on dermoscopy. This year’s workshop is designed to bring attendees up to date with current interpretation of dermoscopic features of specific sites such as the hands and feet, lips, etc. His algorithm and pattern analysis to assist in detecting skin cancer will be stressed. This knowledge will be applied to a set of unknowns, which the audience will help analyze. 		A. Marghoob, MD